Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study
- PMID: 26700026
- PMCID: PMC4690216
- DOI: 10.1186/s12913-015-1229-x
Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study
Abstract
Background: The multidisciplinary approach in the management of Amyotrophic Lateral Sclerosis (ALS) has been shown to provide superior care to devolved care, with better survival, improved quality of care, and quality of life. Access to expert multidisciplinary management should be a standard for patients with ALS. This analysis explores the patient journey from symptom onset and first engagement with health services, to the initial visit to a specialist ALS Multidisciplinary Clinic (MDC) in Dublin, Ireland.
Methods: A retrospective exploratory multi-method study details the patient journey to the MDC. Data from medical interviews and systematic chart review identifies interactions with the health services and key timelines for thirty five new patients presenting with a diagnosis of ALS during a 6 month period in 2013.
Results: The time from first symptom to diagnosis was a mean of 16 months (median 13 months), with a mean interval of 19 months (median 14.6) from first symptoms to arrival at the MDC. The majority of patients were seen by a general practitioner, and subsequently by neurology services. There was an average of four contacts with health services and 4.8 investigations/tests, prior to their first Clinic visit. On the first visit to the MDC patients are linked into an integrated 'system' that can provide specialist care and link with voluntary, palliative and community services as required.
Conclusions: Engagement with a multidisciplinary team has implications for service utilization and quality of life of patients and their families. We have demonstrated that barriers exist that delay referral to specialist services. Comprehensive data recording and collection, using multiple data sources can reconstruct the timelines of the patient journey, which can in turn be used to identify pathways that can expedite early referral to specialist services.
Figures
Similar articles
-
The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population- based study of consultations, interventions and costs.PLoS One. 2017 Jun 22;12(6):e0179796. doi: 10.1371/journal.pone.0179796. eCollection 2017. PLoS One. 2017. PMID: 28640860 Free PMC article.
-
A Qualitative Study of Multidisciplinary ALS Clinic Use in the United States.Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):55-61. doi: 10.3109/21678421.2015.1069851. Epub 2015 Oct 28. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 26508132
-
A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland.J Neurol Neurosurg Psychiatry. 2015 May;86(5):496-501. doi: 10.1136/jnnp-2014-309601. Epub 2014 Dec 30. J Neurol Neurosurg Psychiatry. 2015. PMID: 25550416
-
Multidisciplinary care in Amyotrophic Lateral Sclerosis: a systematic review and meta-analysis.Neurol Sci. 2021 Mar;42(3):911-923. doi: 10.1007/s10072-020-05011-2. Epub 2021 Jan 14. Neurol Sci. 2021. PMID: 33443670 Review.
-
[The patient's opinion matters: experience in the nutritional care in an ALS multidisciplinary team].Nutr Hosp. 2015 May 7;31 Suppl 5:56-66. doi: 10.3305/nh.2015.31.sup5.9132. Nutr Hosp. 2015. PMID: 25938606 Review. Spanish.
Cited by
-
Health care resource utilization and costs across stages of amyotrophic lateral sclerosis in the United States.J Manag Care Spec Pharm. 2024 Nov;30(11):1239-1247. doi: 10.18553/jmcp.2024.30.11.1239. J Manag Care Spec Pharm. 2024. PMID: 39471269 Free PMC article.
-
Reporting and conducting patient journey mapping research in healthcare: A scoping review.J Adv Nurs. 2023 Jan;79(1):83-100. doi: 10.1111/jan.15479. Epub 2022 Nov 3. J Adv Nurs. 2023. PMID: 36330555 Free PMC article.
-
The effect of neuropalliative care on quality of life and satisfaction with quality of care in patients with progressive neurological disease and their family caregivers: an interventional control study.BMC Palliat Care. 2020 Sep 16;19(1):143. doi: 10.1186/s12904-020-00651-9. BMC Palliat Care. 2020. PMID: 32938447 Free PMC article.
-
Iranian clinical practice guideline for amyotrophic lateral sclerosis.Front Neurol. 2023 Jun 2;14:1154579. doi: 10.3389/fneur.2023.1154579. eCollection 2023. Front Neurol. 2023. PMID: 37333000 Free PMC article. Review.
-
Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):533-547. doi: 10.1007/s00259-016-3587-y. Epub 2016 Dec 8. Eur J Nucl Med Mol Imaging. 2017. PMID: 27933416 Review.
References
-
- Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) - revised report of an EFNS task force. Eur J Neurol. 2012;19(3):350–375. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous